Trial Profile
Phase 2b study of Dipraglurant in Parkinson's disease (PD) patients suffering from debilitating levodopa-induced dyskinesia (LID)
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 08 Dec 2016
Price :
$35
*
At a glance
- Drugs Dipraglurant (Primary)
- Indications Drug-induced dyskinesia
- Focus Therapeutic Use
- 08 Dec 2016 New trial record